> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA OKs Romeg Therapeutics’ Liquid Gout Drug
- URL: https://www.fdaweb.com/fda-oks-romeg-therapeutics-liquid-gout-drug/
- Published: 2019-02-26T12:00:00.000Z
- Updated: 2026-09-15T01:07:51.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5143477

FDA has approved a Romeg Therapeutics 505(b)(2) NDA for Gloperba (colchicine) Oral solution, 0.6 mg/5 mL for prophylaxis of gout flares in adults. Gloperba is the first liquid formulation of colchicine approved by FDA for this indication. “Existing therapies do not adequately address the physician’s need to adjust dosages of colchicine to manage the toxicity profile for patients with renal and liver impairments, side effects, common drug-to-drug interactions, and age-related health disorders,” the company says.